Abstract

Melanoma is the most serious type of skin cancer, with a highly metastatic phenotype. In this report, we show that signal transducing adaptor protein 2 (STAP-2) is involved in cell migration, proliferation, and melanogenesis as well as chemokine receptor expression and tumorigenesis in B16F10 melanoma cells. This was evident in mice injected with STAP-2 shRNA (shSTAP-2)-expressing B16F10 cells, which infiltrated organs in a completely different pattern from the original cells, showing massive colonization in the liver, kidney, and neck but not in the lung. The most important finding was that STAP-2 expression determined tyrosinase protein content. STAP-2 colocalized with tyrosinase in lysosomes and protected tyrosinase from protein degradation. It is noteworthy that B16F10 cells with knocked down tyrosinase showed similar cell characteristics as shSTAP-2 cells. These results indicated that tyrosinase contributed to some cellular events beyond melanogenesis. Taken together, one possibility is that STAP-2 positively regulates the protein levels of tyrosinase, which determines tumor invasion via controlling chemokine receptor expression.

Highlights

  • signal transducing adaptor protein 2 (STAP-2) plays important roles in cell migratory functions

  • Manipulation of STAP-2 Expression in Murine Melanoma B16F10 Cells Alters Cell Shape, Cell migration, and Survival in Vitro—We have reported previously that Raw264.7 macrophage cells overexpressing STAP-2 showed impaired migration in response to macrophage colony-stimulating factor (M-CSF) and a diminished wound healing process (27)

  • We uncovered a novel function of STAP-2 in B16F10 melanoma cells

Read more

Summary

Background

STAP-2 plays important roles in cell migratory functions. Results: STAP-2 influences the metastatic phenotype of B16 melanoma. We show that signal transducing adaptor protein 2 (STAP-2) is involved in cell migration, proliferation, and melanogenesis as well as chemokine receptor expression and tumorigenesis in B16F10 melanoma cells. This was evident in mice injected with STAP-2 shRNA (shSTAP-2)-expressing B16F10 cells, which infiltrated organs in a completely different pattern from the original cells, showing massive colonization in the liver, kidney, and neck but not in the lung. One possibility is that STAP-2 positively regulates the protein levels of tyrosinase, which determines tumor invasion via controlling chemokine receptor expression. STAP-2 controls the metastatic property of melanoma cells by modulating the lysosomal degradation of tyrosinase

Experimental Procedures
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call